To determine the feasibility of a community-wide approach integrated with primary care (Cardiovascular Health Awareness Program [CHAP]) to promote monitoring of blood pressure (BP) and awareness of cardiovascular disease risk.
Design.
Demonstration project.
Setting.
Two midsized Ontario communities.
Participants.
Community-dwelling seniors.
Intervention.
CHAP sessions were offered in pharmacies and promoted to seniors using advertising and personalized letters from physicians. Trained volunteers measured BP, completed risk profiles, and provided risk-specific education materials.
Method.
We examined the distribution of risk factors among participants and predictors of multiple visits and elevated BP.
Results.
Opinion leaders aided recruitment of family physicians (n = 56/63) and pharmacists (n = 18/19). Over 90 volunteers were recruited. Invitations were mailed to 4394 seniors. Over 10 weeks, there were 4165 assessments of 2350 unique participants (approximately 30% of senior residents). 37.5% of attendees had untreated (16%; 360/2247) or uncontrolled (21.5%; 482/2247) high BP. Participants who received a letter (odds ratio [OR] 2.5, 95% confidence interval [CI] 2.1–3.0), had an initial elevated BP (OR 1.2, 95% CI 1.0–1.5), or reported current antihypertensive medication (OR 1.4, 95% CI 1.1–1.6) were more likely to attend multiple sessions (p ≤ .05 for all). Older age (≥ 70 years; OR 1.5, 95% CI 1.3–1.8), BMI ≥ 30 (OR 1.7, 95% CI 1.4–2.2), current antihypertensive medication (OR 1.6, 95% CI 1.3–1.9), and diabetes (OR 2.4, 95% CI 1.9–3.2) predicted elevated BP (p < .001 for all).
Conclusion.
The program yielded learning about community mobilization and identified a substantial number of seniors with undiagnosed/uncontrolled high BP.
ManuelDGLeungMNguyenK. Burden of cardiovascular disease in Canada. Can J Cardiol. 2003;19:997–1004.
2.
MurrayCJLLopezAD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, Mass: Harvard School of Public Health; 1996.
3.
Heart and Stroke Foundation of Canada. The growing burden of heart disease and stroke in Canada 2003. Available at: http://www.cvdinfobase.ca/cvdbook/CVD_En03.pdf. Accessed June 11, 2007.
4.
LangilleDBJoffresMRMacPhersonKM. Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: Results from the Canadian Heart Health Surveys, 1986–1992. CMAJ. 1999;161:S3–S9.
5.
KirklandSAMacLeanDRLangilleDB. Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: Results from the Canadian Heart Health Surveys. CMAJ. 1999;161:S10–S16.
6.
YusufSHawkenSÔunpuuS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937–952.
7.
FusterVKellyBBVedanthanR. Global cardiovascular health: Urgent need for an intersectoral approach. J Am Coll Cardiol. 2011;58:1208–1210.
8.
HemmelgarnBRMcAlisterFAGroverS. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I—blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2006;22:573.
9.
KhanNAHemmelgarnBPadwalR. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2—therapy. Can J Cardiol. 2007;23:539–550.
10.
JoffresM. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997;10:1097–1102.
11.
JonesDWAppelLJShepsSG. Measuring blood pressure accurately: New and persistent challenges. JAMA. 2003;289:1027–1030.
12.
MacLeanDRPetrasovitsANargundkarM. Canadian heart health surveys: A profile of cardiovascular risk. Survey methods and data analysis. CMAJ. 1992;146:1969–1974.
13.
RoseG. Strategies of prevention: The individual and the population. In: MarmotMElliotP, eds. Coronary Heart Disease Epidemiology: From Aetiology to Public Health. New York, NY: Oxford University Press; 2005:631–641.
14.
SargentRPShepardRMGlantzSA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: Before and after study. BMJ. 2004;328:977–980.
15.
BartecchiC. A city-wide smoking ordinance reduces the incidence of acute myocardial infarction. Paper presented at: American Heart Association Annual Scientific Sessions; 2005; Dallas, Tex.
16.
StoneEJPearsonTAFortmannSPMcKinlayJB. Community based prevention trials: Challenges and directions for public health practice, policy, and research. Ann Epidemiol. 1997;7(7 suppl):S113–S120.
17.
SchoolerCFarquharJWFortmannSPFloraJA. Synthesis of findings and issues from community prevention trials. Ann Epidemiol. 1997;7(7 suppl):S54–S68.
18.
PearsonTAStoneEJGrundySM. Translation of nutritional sciences into medical education: The Nutrition Academic Award Program. Am J Clin Nutr.2001;74:164–170.
19.
PuskaP. Community change and the role of public health. In: MarmotMElliotP, eds. Coronary Heart Disease Epidemiology: From Aetiology to Public Health. New York, NY: Oxford University Press; 2005:893–907.
20.
VerheijdenMWKokFJ. Public health impact of community-based nutrition and lifestyle interventions. Eur J Clin Nutr.2005;59(suppl 1):S66–S76.
21.
KarwalajtysTKaczorowskiJChambersLW. A randomized trial of mail vs. telephone invitation to a community-based cardiovascular health awareness program for older family practice patients. BMC Fam Pract.2005;6:35.
22.
CHAP Working Group. CHAP: A community approach to better cardiovascular health! Available at: http://www.chapprogram.ca. Accessed April 19, 2007.
23.
VSM MedTech. BpTRU: Medical advances through technology. Available at: http://www.bptru.com/. Accessed April 19, 2007.
BeckettLGodwinM. The BpTRU automatic blood pressure monitor compared to 24-hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2005;5:18.
26.
GravesJWNashCBurgerK. Clinical decision making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003;17:823–827.
ValenteTWPumpuangP. Identifying opinion leaders to promote behavior change [published online ahead of print June 27, 2009]. Health Educ Behav.2007;34:881–896.
36.
PosavacEJKattapongKRDewDEJ. Peer-based interventions to influence health-related behaviors and attitudes: A meta-analysis. Psychol Rep.1999;85:1179–1194.
WagnerEH. Chronic disease management: What will it take to improve care for chronic illness?Eff Clin Pract.1998;1:2–4.
39.
KarwalajtysTMcDonoughBHallH. Development of the volunteer peer educator role in a community Cardiovascular Health Awareness Program (CHAP): A process evaluation in two communities. J Community Health. 2009;34:336–345.
40.
SullivanSMKaczorowskiJMyersMGKarwalajtysTChambersLW. Use of automated blood pressure measurement to reduce white coat response in a pharmacy setting. Canadian Journal of Cardiology. 2007;23(SC):85c.
41.
LemeshowSHosmerDWJr. A review of goodness of fit statistics for use in the development of logistic regression. Am J Epidemiol. 1982;115:92–106.
42.
KarwalajtysTKaczorowskiJHutchisonB. Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide program. J Hum Hypertens. 2009;23:585–589.
43.
MerzelCD'AfflitiJ. Reconsidering community-based health promotion: Promise, performance, and potential. Am J Public Health. 2003;93:557–574.
44.
MittelmarkMBHuntMKHeathGWSchmidTL. Realistic outcomes: Lessons from community-based research and demonstration projects for the prevention of cardiovascular diseases. J Public Health Policy. 1993;14:437–462.
45.
MittelmarkMBLuepkerRVGrimmR. The role of physicians in a community-wide program for prevention of cardiovascular disease: The Minnesota heart health program. Public Health Rep.1988;102:360–365.
46.
PetrellaRJMerikleEPJonesJ. Prevalence, treatment and control of hypertension in primary care: Gaps, trends and opportunities. J Clin Hypertens. 2007;9:28–35.
47.
ChobanianAVBakrisGLBlackHR. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 report. JAMA. 2003;289:2560–2572.
48.
The Hypertension in Diabetes Study Group. Hypertension in diabetes study (HDS): Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens. 1993;11:319–325.
49.
Resource utilization and costs of care in the diabetes control and complications trial. Diabetes Care. 1995;18:1468–1478.
50.
ManciaG.Optimal control of blood pressure in patients with diabetes reduces the incidence of macro- and microvascular events. J Hypertens Suppl.2007;25(suppl 1):S7–S12.
51.
MaJThabaneLKaczorowskiJ. Comparison of Bayesian and classical methods in the analysis of cluster randomized controlled trials with a binary outcome: The Community Hypertension Assessment Trial (CHAT). BMC Med Res Methodol. 2009;9:37.
52.
ElderJPSchmidTLDowerPHedlundS. Community heart health programs: Components, rationale, and strategies for effective interventions. J Public Health Policy. 1993;14:463–479.
53.
McLarenLGhaliLMLorenzettiDRockM. Out of context? Translating evidence from the North Karelia project over place and time. Health Educ Res.2007;22:414–424.
54.
BroomfieldJSchiedaNSullivanSM. Recording blood pressure readings in elderly patients' charts: What patient and physician characteristics make it more likely?Can Fam Physician. 2008;54:230–231.
55.
KaczorowskiJChambersLWDolovichL. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ. 2011;342:d442.
56.
CarterMKarwalajtysTChambersLW. Implementing a standardized community-based cardiovascular risk assessment program in 20 Ontario communities. Health Promot Int.2009;24:325–333.
